Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill Patients

NCT04982055 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Critical Illness

Interventions

DRUG: Nadroparin (intravenous Infusion)
DRUG: Nadroparin (subcutaneous group)

Sponsor

Clinique Saint Pierre Ottignies